Intervet/Schering-Plough has announced that Estrumate^®, in both the 10ml and 20ml vial size is back in stock and available to order from your veterinary wholesaler.

The stock out situation had arisen as a result of increased demand during the early part of the year but the company is confident that there will be sufficient stock to supply the increased level of demand in the foreseeable future. Intervet/Schering-Plough would like to thank their clients for the patience and understanding.

Further information is available from Intervet/Schering-Plough Account Managers or the Veterinary Support Group (VSG) on 01908 685685.

Bob Martin has launched FleaClear (fipronil) for cats and dogs, which will be sold through multiple retailers and leading pet retailers for as little as £4.50 per treatment.

The company says it is backing the launch with 'considerable marketing spend', which will include TV advertising, a press campaign in women's consumer lifestyle titles, PR and social media campaigns.

According to the company's press release:  "Not only is it cheaper than Frontline it can be bought off the shelf saving a costly visit to the vets."

Indeed. Not to mention the savings to be made by not having to hospitalise the permethrined cat.

The industry-led Cattle Health and Welfare Group of Great Britain (CHAWG) has published a review which identifies a practical approach to gathering antibiotic usage data on UK cattle farms.

The review outcomes, announced today at a joint conference held by the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the Veterinary Medicines Directorate (VMD), highlight the significant benefits better data could deliver, such as improving the way antibiotics are administered strategically to tackle disease.

But CHAWG’s chair Tim Brigstocke says it’s also important that the industry is able to accurately report usage levels because of the rising levels of antibiotic-resistant bacteria which threaten human health. 

"We found that while data is already stored at every vet practice and in every farm medicine book, it currently exists in many different forms. It’s also not collected or collated, and is further complicated by multi-species approvals for many of the antibiotics.

"This means we can’t always be sure in which type of animal a medicine has been used. For example, out of 420 tonnes of animal-authorised antibiotic active substance sold in the UK in 2013, only 14 tonnes was authorised solely for use in cattle. However, 63 tonnes was authorised for multi-species use in food producing animals and within the 217 products included in this, 201 are authorised for use in cattle."

Tim says that with the support of the VMD, which requested the review and will now act as secretariat, CHAWG will set up a working group to implement the report’s recommendations.

The starting point is likely to be the survey of vets carried out by the British Cattle Veterinary Association (BCVA), which formed part of the review. This suggested vets could be using as many as 15 different software programmes to log data, so CHAWG will be working with the BCVA and individual practices to look at how standard sets of data can be anonymised and exported.

"Then we will almost certainly look at how cattle farmers can be supported in migrating records from the physical ‘medicine book’ on the farm, into a spreadsheet or existing cattle management software for anonymous aggregation on a national level.

"There are undoubtedly areas where we can improve the effectiveness of how we use these powerful medicines to improve welfare. But the antibiotic resistance debate is an emotive one and we must also demonstrate accountability to ensure the preservation of antibiotics for future use in humans and animals; any future curbs on usage should be proportionate and informed, and not compromise animal wellbeing."

Mandatory reporting in Europe could be just over the horizon and the European Medicines Agency has focused in the past year on developing a method for data collection on the usage of antibiotics in the EU pig sector. In the UK, the VMD is encouraging the livestock sectors to develop systems appropriate to their own unique circumstances and industry characteristics.

Tim said: "It’s therefore in cattle farmers’ own interests to anticipate the kind of figures it might be asked to supply in the future, and develop a way of collecting that data which suits the way the UK industry works.

"Then we can retain control over the data and the methodology, and ensure the reporting is accurate – and this in turn will help the VMD represent our case better in Europe as this debate continues.

CHAWG says that throughout this project, it will be liaising with others – such as the pig sector – to ensure learnings are shared, duplication avoided and efficiencies realised where possible. 

The CHAWG review report is available to download at www.chawg.org.uk.

Genitrix has announced that HY-50 Vet^®, a sodium hyaluronate treatment for equine joints, has now been authorised for intravenous (IV) use.

Available until now for intra-articular (IA) use only, the company says HY-50 delivers the highest concentration of sodium hyaluronate on the market for the treatment of non-infectious joint inflammation and the enhancement of joint function. 

Genitrix also says that, as IV application requires less specialist preparation than IA, HY-50 is now a practical solution for mixed practices with a smaller equine case load.  Injected intravenously, the product will also benefit horses with multiple joint injuries.

HY-50 is presented in a 3 ml pre-loaded syringe, delivering 50 mg of sodium hyaluronate.  It costs £55.50.

Rob Watkins, Marketing Director of Genitrix, said: "The efficacy of sodium hyaluronate is well established and we're delighted to be able to offer the IV route of administration.  We know it will meet a real need in the market for a lameness treatment which is proven and simple to administer."

"Perhaps most importantly, in these financially difficult times, the high concentration of the product makes it a cost-effective approach compared with competitive products.  We believe it will offer an affordable treatment option for owners who are anxious to treat their horses but may be discouraged by the high cost of many treatments."

For further information, see http://www.genitrix.co.uk/ or ring 01403 786345.

Norbrook Laboratories has produced a new pet owner advice booklet: The Guide to Safe Flea Treatment with the help of the Veterinary Poisons Information Service.

The booklet, which sits alongside a range of marketing materials to support Pestigon, the company's new spot on for cats and dogs, details the dangers of certain spot on products when used in the incorrect species, the risks of buying veterinary medicines online and the benefits of implementing a complete flea treatment program to treat the household and animal.

Michelle Jones, Norbrook's Small Animal Brand Manager said: "For pet owners, an infestation of fleas can be a nightmare. The Guide to Safe Flea Treatment has been produced to help pet owners, under the advice of their vet, understand the potential issues that could be faced with purchasing decisions when dealing with flea and tick infestations."

She added: "Pestigon was launched recently as a POM-V product and is sold exclusively through veterinary practices. The Guide to Safe Flea Treatment is available as part of a wider number of support materials available from Norbrook Laboratories including a useful waiting room display pack which will help support vets when prescribing the product and discussing flea treatments with their clients. "

The Guide to Safe Flea Treatment and other supporting materials are available through your Norbrook representative. 

An annual dog licence fee of as little as £21.50¹ could help reduce the number of strays and help tackle irresponsible dog breeding, according to a new RSPCA report released today.

Owners would face a cost of less than 42p a week per dog, in order to provide huge improvements to dog welfare and dog control services.

The report - 'Improving dog ownership - The economic case for dog licensing' - suggests a licensing scheme could deliver resources to improve dog welfare worth in excess of £107.4 million¹. With an estimated 10 million dogs in Britain², this works out at £21.50 per dog with a compliance rate of 50 per cent¹. A compliance rate of 75 per cent would work out even less at £14.30 per dog¹.

The new report was written by the RSPCA's director of communications David Bowles and is based on research by Reading University, which was commissioned by the Society.

It makes three recommendations in its conclusion: 

• The government should establish a dog health and welfare strategy underpinned and funded by a dog licence scheme. This would fund resources to tackle the issues, such as strays, injuries caused by dog bites and the prevention of disease, as covered in the report.
• The scheme could be set at £20-£30 per dog annually, with discounts for selected dogs (e.g. assistance dogs, neutered dogs) and people (e.g. pensioners).
• Microchips would be used to identify the dogs, with details entered on a national database, improving dog ownership and reducing numbers of unwanted dogs.

David said: "Now is the right time to invest in the future health and welfare of Britain's dogs. A dog licence would raise money which could be targeted into improving enforcement of laws at a local level, improve the welfare of dogs and reverse the use of certain breeds of dogs as a status symbol or weapon.

"The dog licence would achieve three important goals. It would raise money for dog welfare, increase the numbers of responsible dog owners by getting people to think before they get a dog and start to reverse the surplus of dogs on the market by providing incentives such as reduced fees for neutering dogs."

He added that the costs are given as an indication of what the licence fee could cover, and a dog licensing scheme could in reality be set at between £20-30 per dog per year - between only three and four per cent of the annual costs of owning a typical breed of dog.

Twenty-three countries in Europe currently have a dog licence or registration scheme³. In some countries, such as Germany, Slovenia and the Netherlands, the RSPCA says there have been improved dog control provisions and low numbers of strays with compliance rates of more than 50 per cent.

David said: "The RSPCA believes that Britain has slipped behind other countries which have started to tackle and solve the problems of dog over supply and only the introduction of a dog licence could ensure we catch up.

"In countries which have a dog licence it is seen not as a tax, but as an important part of owning a dog. In Britain we know that a dog licence is welcomed by two out of every three dog owners, more than 70 per cent of who are happy to pay more than £30 for the pleasure and responsibility of owning a dog."

References
1. Figures taken from Table 2, p16, Improving dog ownership - The economic case for dog licensing (see below).
2. Murray, J.K., Browne, W.J., Roberts, M.A., Whitmarsh A. And Gruffydd-Jones T.J. (2010) Number and ownership profiles of cats and dogs in the UK. The Veterinary Records 166: 163-168.
3. Tasker, L. (2007) Stray Animal Control Practices (Europe). WSPA and RSPCA.

Norbrook has launched an Android version of its existing free iPhone app: ‘the Veterinary Excellence Tool’ (VET).

VET offers a range of functions to assist veterinary professionals and farmers including a product dosing calculator. The Android version has been developed to meet customer demand and has the same features as the Apple version which is available for both iPhones and iPads.

Norbrook highlights the following features of the app:

• A product dosing calculator that allows product dosage to be calculated in seconds
• Full and most up-to-date product listing of UK products
• A Territory Manager locator with full contact details
• A new events section
• A fluid calculator which allows users to quickly and conveniently calculate infusion rates based on factors including a patient’s weight, reason for fluid therapy and choice of product to be infused.
• A nutrition calculator which calculates daily food intake based on animal weight, calorie density of food and nutritional requirements. It also calculates the approximate energy density of food based on fat, protein and carbohydrate requirements, where this information is not readily available.

The app can be downloaded for free by searching for “Norbrook” in either app store.

For further information please contact Laura Holmes, E-Marketing Manager, laura.holmes@norbrook.co.uk or 01536 741147.

The RCVS Veterinary Nurse Disciplinary Committee has ruled that Somerset-based William Kane is fit to practice after he was convicted of three counts of causing serious injury by dangerous driving.

Mr Kane was sentenced to two years’ imprisonment, suspended for 18 months in September 2024.

He was also disqualified from driving for two years until he had passed an extended driving test, and was ordered to undertake 200 hours of unpaid work within 12 months, and to pay a victim surcharge of £187.

It was alleged that the conviction rendered Mr Kane unfit to practise as a veterinary nurse.

From the outset, Mr Kane admitted the facts contained in the charge, but did not accept that this rendered him unfit to practise as a veterinary nurse.

After the criminal proceedings, Mr Kane wrote to express his deepest regret for his actions and the pain and guilt they had caused, stating that there was not a single day that had passed that he had not thought about the family that was affected by his actions, and the lifelong consequences that they now face.

He went on to express that he understood that as a member of a trusted profession, his conduct must reflect not only his clinical competence, but also his integrity and accountability.

He also noted that he had sought to recognise and address the consequences of his actions and that he is determined to make a positive contribution to society and to the profession.

The Committee found the charge proved on the basis of Mr Kane’s admission and the Certificate of Conviction.

The Committee found a number of factors relevant to the case:

• there was no explanation for the accident
• Mr Kane was not intoxicated, nor was he distracted by using his mobile phone
• he was not carrying out any type of manoeuvre, for example overtaking where he shouldn’t
• his car was not in a dangerous condition
• no concerns had been raised about the manner of his driving, other than the moment immediately before the collision
• the judge repeatedly described the accident as a ‘momentary lapse of attention’, whereby Mr Kane’s car drifted into the opposing lane of traffic for a couple of seconds and there was then a catastrophic collision
• whilst the consequences were severe, the culpability, said the judge, was low and just crossed the threshold between careless and dangerous driving;
• the judge found there to be no aggravating features
• the judge, who had the benefit of watching dash-cam footage from another car that captured the collision, described it as a ‘mistake’.

The question for the Committee was whether Mr Kane’s conviction of causing serious injury by dangerous driving, when put into proper context, rendered him unfit to practise as a veterinary nurse.

This was not a conviction in any way linked to his practise and there was no suggestion that he represented any sort of a risk to animals in his care.

The Committee was not, therefore, concerned with any issues arising out of the need to protect animals, but rather with whether a finding of unfitness to practise was needed to uphold standards of conduct and behaviour in order to maintain public confidence in the profession.

Kathryn Peaty, Chair of the Committee and speaking on its behalf, said: “The Committee took into account the public interest which includes maintaining public confidence in the profession and the regulator and upholding proper standards in the profession.

"The public interest also includes allowing an otherwise competent veterinary nurse to continue in practice, where appropriate.

“Agreeing with the judge that this was indeed an exceptional case, the Committee did not consider that Mr Kane’s conduct was liable to have a seriously detrimental effect on the reputation of the profession and concluded that the public, in full knowledge of the circumstances of this particular case, would not expect a finding that the conviction renders him unfit to practise as a veterinary nurse.

"Rather, the public would recognise that whilst the consequences were appalling and tragic for the family involved, in terms of Mr Kane’s culpability this was a momentary piece of dangerous driving, categorised by the judge as a ‘mistake’ rather than anything more blameworthy.

“The Committee therefore concluded that Mr Kane’s conviction does not render him unfit to practise as a veterinary nurse.

"This is not to in any way detract from the catastrophic consequences for the family, but rather is to reflect the context, exceptional circumstances and level of culpability in this case.”

https://www.rcvs.org.uk/concerns/disciplinary-hearings/ 

The organisers of the Vet Charity Challenge have announced that the 2015 fundraising and teambuilding event for the profession will take place on Saturday 26th September at Cannock Chase in Staffordshire.

The event consists of teams of four walking/running, cycling and kayaking as well as some orienteering and mental and physical tasks. The day is designed for every level of fitness and to reward those that work the best together as a team.

So far the Vet Charity Challenge has raised over £100,000 for animal based charities. In 2015 the charities being supported are Canine Partners, SPANA and International Cat Care.

Registration for the event opens online at the start of April. Organisers say that spaces are limited and last year filled up very fast, so to avoid disappointment it is highly recommended to book early.

This year there will be discounted entry fees for students teams.

Gavin Mitchell from BCF Technology said: “We were delighted at the success of the Vet Charity Challenge so far. Last year we had 50 teams taking part and raised a serious amount of cash for three very deserving charities. We hope to top this in 2015, making the event even bigger and better than last year.” 

Dechra Veterinary Products has joined the challenge as a new sponsor this year. Larry King, Dechra Marketing Manager said: “Having entered a team into the Vet Charity Challenge in previous years, we are delighted to become sponsors of the challenge in 2015. The Vet Charity Challenge helps raise a significant amount of money for worthwhile causes at home and abroad and we look forward to being part of such a well organised event. This year we will be entering teams into the challenge again and we hope that colleagues from across the veterinary industry join us for what is sure to be a fun-packed weekend. We are proud to be 2015 sponsors.”

In addition to BCF and Dechra, the event is also sponsored by Kruuse, the VPMA, Mojo Consultancy and Veterinary Practice magazine.

For more information visit www.vetcharitychallenge.co.uk or: https://www.facebook.com/vetcharitychallenge.

A new study, published in the Equine Veterinary Journal (EVJ)¹ has concluded that whilst horse owners are increasingly looking to vets for worm control advice and use faecal worm egg counts more frequently, they remain largely unaware of the threat of resistance to dewormers and the importance of appropriate 'targeted' dosing.

The authors of the study say that although the findings are encouraging, they indicate that further effort is needed to help owners fully understand the issue of dewormer resistance, in order to help preserve the efficacy of dewormers currently available and protect the health and welfare of their horses.

According to the British Equine Veterinary Association (BEVA), resistance of equine gastrointestinal worms to the currently available dewormers is a serious problem. The association says small redworm are the greatest concern, given their very high prevalence, potential to cause life-threatening disease and high levels of resistance. Of the three classes of anthelmintic available for their control, there is now widespread resistance to benzimidazoles (e.g. fenbendazole) and tetrahydropyrimidines (e.g. pyrantel) and reduced effectiveness of macrocyclic lactones (ivermectin and moxidectin). With no new classes of dewormer on the horizon, it's essential that efficacy of existing effective products is preserved.

The study was conducted by a UK team, led by Claire Stratford, Horse Trust Clinical Scholar in Equine Medicine at the Royal (Dick) School of Veterinary Studies, and at Moredun Research Institute. The collaborators were also supported by funding from the Elise Pilkington Trust and Horserace Betting Levy Board.

The study examined equine helminth control practices in Scotland, and was based on responses from 193 questionnaires detailing the parasite control programmes of 993 horses and ponies. The results demonstrated a lack of awareness of the significance of dewormer resistance, with 86% of respondents stating that they were unaware of the presence of resistance on their yard. The majority were relatively unconcerned about dewormer resistance, assigning a score of only 6/10 (with 10 representing highest level of concern) when asked to grade how important they perceived it to be.

On a more positive note, many respondents stated that they involved their vet in planning control strategies. Faecal worm egg count (FWEC) analysis had been performed on 62% of yards and annual treatment frequency had been reduced accordingly. The macrocyclic lactones or related combination products were the most commonly administered products; however, owners did have misconceptions regarding the specific worms they should be targeting.

Although treatments licensed for use against encysted small redworm larvae were administered by 80% of respondents, only 57% perceived that they treated for this parasite stage. Similarly, only 78% of respondents believed they were treating for tapeworm when, in fact, 90% reported using a product licensed for tapeworm treatment.

While responses indicated increased implementation of strategic (44% respondents) or targeted control (40% respondents), variations in the apparent influence of the targeted approach on treatment practices suggested some confusion over this term. Claire Stratford said: "Targeted dosing involves using regular FWEC analysis to identify an individual's egg shedding level. This is currently considered best practice, when used in conjunction with annual dosing against encysted small redworm and tapeworm. The survey indicates a need for continued knowledge transfer, together with a consistent definition of 'targeted' treatment."

Professor Celia Marr, Editor of Equine Veterinary Journal said: "It's very encouraging to see that vet advice is being increasingly sought and it seems logical that the use of FWECs is rising accordingly. But, it is equally important that the information gained from the FWECs is used wisely. Resistance to dewormers is a major health concern that is with us right now and horse owners need to be made more aware of it."

Reference

1. A questionnaire study of equine gastrointestinal parasite control in Scotland CH Stratford, HE Lester, ER Morgan, KJ Pickles, V Relf, BC McGorum, JB Matthews

The WSAVA has launched a petition to save ketamine from being placed under international scheduling, a move which the association says would prevent those who most need the drug having access to it.

The proposal to schedule ketamine is likely to be considered at the 59th UN Convention on Narcotic Drugs (CND) taking place between now and the 22nd March 2016 in Vienna.

Apparently, the proposal stems from a widespread misconception that ketamine is only a recreational drug. WSAVA argues that it is in fact the only anaesthetic suitable for use in middle and low income countries, and it also has particular value 'in the field' for trauma, traffic and sporting injuries. It is also the common and often only product used for sterilization initiatives - instrumental in the feral dog/cat population and critical for the control of zoonotic diseases, such as rabies.

To sign the petition, visit: http://chn.ge/1RFSou6. You can also share the petition post on facebook: https://www.facebook.com/WSAVA/.